Onderneming AroCell AB (publ) Nasdaq Stockholm
Aandelen
SE0003883990
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
SEK in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Research and Development in Cell Biology and Medicine
100,0
%
| 0 | 100,0 % | 12 | 100,0 % | +14.180,95% |
Verkoop per regio
SEK in miljoen | 2020 | Gewicht | 2021 | Gewicht | Delta |
---|---|---|---|---|---|
Sweden
100,0
%
| 0 | 100,0 % | 12 | 100,0 % | +14.180,95% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Anders Hultman
CEO | Chief Executive Officer | 50 | 01-12-18 |
Lars Jakobsson
DFI | Director of Finance/CFO | 67 | - |
Gustav Sten
COO | Chief Operating Officer | - | 01-01-19 |
Gunnar Steineck
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Chief Tech/Sci/R&D Officer | - | 01-01-15 | |
Alona Nyberg
IRC | Investor Relations Contact | - | 01-01-19 |
Gunnar Wahlberg
SAM | Sales & Marketing | 54 | 01-01-21 |
Tina Yang
PRN | Corporate Officer/Principal | - | 01-01-17 |
Peter Lowendahl
LAW | General Counsel | - | 01-01-19 |
Filip Fogdestam
PRN | Corporate Officer/Principal | - | 01-01-14 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 65 | 01-01-22 | |
Director/Board Member | 63 | 01-05-21 | |
Clas Runnberg
BRD | Director/Board Member | 72 | 01-01-23 |
Gunnar Steineck
CTO | Chief Tech/Sci/R&D Officer | - | 01-01-17 |
Max Pihlqvist
BRD | Director/Board Member | 37 | 01-01-22 |
Eva Nordström
BRD | Director/Board Member | 54 | 01-01-20 |
Director/Board Member | - | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 230 361 066 | 102 183 486 ( 44,36 %) | 0 | 44,36 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+17,96% | 44,96 mld. | |
+1,17% | 42,65 mld. | |
+48,77% | 41,85 mld. | |
-4,27% | 29,04 mld. | |
+11,42% | 26,08 mld. | |
-21,39% | 19,03 mld. | |
+4,86% | 12,75 mld. | |
+27,29% | 12,06 mld. | |
-3,50% | 11,75 mld. |